Articles by Larissa Ku
China's Avistone Pharmaceuticals raises $200m
Avistone Pharmaceuticals, a Beijing biotech company focused on precision oncology therapeutics has raised more than $200 million in a Series A funding round led by Vivo Capital.
China's ABclonal Technology raises $189m
Chinese life science research and diagnostic reagents provider ABclonal Technology has raised a RMB1.2 billion ($189 million) Series D round featuring Sequoia Capital China.
L Catterton backs China-based Amazon vendor aggregator
Nebula Brands, a China-based aggregator of Amazon vendors, has raised $50 million in Series B funding led by L Catterton Asia.
Singapore's Aura acquires Australia vaccination player
Singapore-based Aura Private Equity has acquired a majority stake in Australian Vaccine Services (AVS), a leading provider of corporate flu vaccinations.
Fund focus: Lightspeed bets on green-tech
Green-tech is the latest big idea being championed by Lightspeed China Partners. It has inspired a change in the firm’s name and it will underpin deployment of the new $920 million fund
Deal focus: Gaussian serves China's aged
With its globally competitive technology and low costs, Gaussian Robotics has become a dominant force in the cleaning robot segment. SoftBank Vision Fund is the latest addition to its cap table
China surgical robotics player RainMed raises $100m
Ping An Capital has led a Series D round of approximately $100 million for RainMed Medical, a China-based surgical robotics business. Other investors include Seresia Asset Management and Lighthouse Canton.
China 3D printing start-up WeNext raises $55m
Temasek Holdings, Cathay Capital Private Equity, and Haochen Capital have led a $55 million Series B round for WeNext Technology, a China-based 3D printing specialist.
China blockchain security company Certik raises $80m
China and US-based blockchain security company Certik has raised $80 million in the third tranche of a Series B round led by Sequoia Capital China.
China cleantech: Policy tailwinds
Private equity investment in China cleantech and renewables is at record levels, spurred by robust government support for the industry and a recognition that this time the boom might be sustainable
Lightspeed China closes US dollar fund at $920m
Lightspeed China Partners has closed its latest US dollar-denominated fund at $920 million. It is the largest fund raised by the firm and brings assets under management to $3 billion.
China procurement services start-up raises $102m
Chinese procurement management platform Going-Link, also known as Zhenyun, has raised a RMB650 million ($102 million) Series C round led by Meituan-backed DragonBall Capital.
Qiming leads $40m round for Allorion Therapeutics
China and US-based precision medicine company Allorion Therapeutics has raised a $40 million Series A round led by Qiming Venture Partners.
Secondaries supply-demand mismatch most extreme in Asia - AVCJ Forum
There is not enough capital in Asia to address the number of secondary opportunities – mirroring the situation globally – with investors claiming to have more transaction choices than ever before.
China GPU chip designer secures $313m Series A
Moore Threads, a Chinese chip designer established 13 months ago by a team from Nvidia, has closed Series A at RMB2 billion ($313 million) led by Shanghai Guosheng Capital, 5Y Capital, and a BOC International fund.
China ocular drugs developer raises $63m
China’s Neurophth Biotechnology, a gene therapy developer for ocular diseases, has raised a RMB400 million ($63 million) Series C round led by SDIC China Merchants Investment and Sequoia Capital China.
China IPOs: The star still wanes
Proceeds from private equity-backed offerings on China’s Star Market are down 75% from their peak one year ago, reflecting ongoing regulatory interference and diminished investor confidence
Investors see China regulatory turbulence as short-term - AVCJ Forum
Regulatory uncertainty overshadowing China's technology sector is a temporary phenomenon, investors told the AVCJ Private Equity & Venture Forum, while noting that targeting areas favored by the government remains a safe play.
Warburg Pincus backs China new materials business
Ambilight, a China-based new materials company focused on electrochromic (EC) components, has raised several hundred million dollars in Series C funding led by Warburg Pincus.
Local turbulence drives China tech players abroad - AVCJ Forum
Regulatory uncertainty in China has encouraged local technology companies to go global rather than rely on a single market, the AVCJ Private Equity & Venture Forum heard.
Xiaomi invests $70m in China LiDAR specialist Hesai
Xiaomi Industrial Investment Fund, a vehicle controlled by smart devices brand Xiaomi, has invested $70 million in Hesai Technology, a China-based developer of sensors used in autonomous driving.
Investors get tough on diversity - AVCJ Forum
Investors are pressing GPs and portfolio companies to do more on gender and cultural diversity, pointing to evidence that greater parity boosts performance, the AVCJ ESG Forum heard.
CMC, Goldman lead $150m round for China's Cyclone Robotics
Cyclone Robotics, a Shanghai-based robotic process automation (RPA) start-up, has raised $150 million in a Series C round led by CMC Capital Group and Goldman Sachs Asset Management.
Vision Fund backs China cleaning robot maker
SoftBank Vision Fund 2 and Capital Today have led a RMB1.2 billion ($188 million) Series C round for Chinese cleaning robot maker Gaussian Robotics.